Cost Savings Utilizing Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in Physician Operated Infusion Centers (POICs) without Hospitalization

Presented on October 27, 2009

Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX
Michael P. Dailey, MD – Infectious Disease Services of GA, Roswell, GA
Andrew H. Krinsky, MD – Infectious Disease Associates, Sarasota, FL
John S. Adams, MD – Knoxville Infectious Disease Consultants, Knoxville, TN

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.